Search

Author/Creator Schleicher, Michael

2. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. Issue 3 (March 2018)

Authors:
Moser, Stephan; Kozbial, Karin; Laferl, Hermann; Schütz, Angelika; Reiberger, Thomas; Schwabl, Philipp; Gutic, Enisa; Schwanke, Cornelia; Schubert, Raphael; Luhn, Julian; Lang, Tobias; Schleicher, Michael; Steindl-Munda, Petra; Haltmayer, Hans; Ferenci, Peter; Gschwantler, Michael
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 30:Issue 3(2018:Mar.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Factors associated with misreporting in performance‐based financing in Burkina Faso: Implications for risk‐based verification. (17th April 2019)

Authors:
Kuunibe, Naasegnibe; Lohmann, Julia; Schleicher, Michael; Koulidiati, Jean‐Louis; Robyn, Paul Jacob; Zigani, Zambendé; Sanon, Adama; De Allegri, Manuela
Journal:
International journal of health planning and management
Issue:
Volume 34:Number 4(2019)
Page Start:
1217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗